Katie Murray, DO
Urology · New York, NYNPI 1235372715
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $427,000 of the $574,807 with a category attached, or 74.3%. Urogen Pharma, Inc. accounts for 81.4% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $210,925, more than ten times the $438 reported in 2019. Among urology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 704 payments — averaging $816.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogen Pharma, Inc.$468K
- Ferring Pharmaceuticals Inc.$78K
- Janssen Scientific Affairs, LLC$9K
- Johnson & Johnson$6K
- Janssen Global Services, LLC$3K
- E.r. Squibb & Sons, L.L.C.$2K
- plus $8K from 19 others
Across 53 payments — averaging $3789.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$128K
- Seagen Inc.$39K
- Pfizer$31K
- Urogen Pharma, Inc.$4K
What the payments were for
- Consulting fees$60,22110%
- Speaking & faculty fees$427,00074%
- Travel & lodging$66,54312%
- Food & beverage$20,5274%
- Education$5170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogen Pharma, Inc. | 435 | $467,800 |
| Ferring Pharmaceuticals Inc. | 93 | $78,084 |
| Janssen Scientific Affairs, LLC | 22 | $9,432 |
| Johnson & Johnson(2 entities) | 20 | $5,958 |
| Janssen Global Services, LLC | 3 | $3,321 |
| E.r. Squibb & Sons, L.L.C. | 2 | $2,300 |
| AstraZeneca | 1 | $2,148 |
| Boston Scientific | 27 | $1,622 |
| Immunitybio, Inc. | 3 | $1,534 |
| Coloplast | 68 | $626 |
| Astellas Pharma US Inc | 4 | $319 |
| Janssen Research & Development, LLC | 5 | $280 |
| Cook Incorporated | 1 | $250 |
| Pfizer | 2 | $168 |
| Kerecis Limited | 1 | $151 |
| Convatec Inc. | 6 | $147 |
| Procept Biorobotics Corporation | 1 | $146 |
| Bayer | 1 | $143 |
| Merck | 2 | $121 |
| Ambu Inc. | 1 | $55 |
| Laborie Medical Technologies Corp. | 2 | $55 |
| Medtronic | 1 | $49 |
| Myovant Sciences Inc. | 1 | $47 |
| Dendreon Pharmaceuticals LLC | 1 | $28 |
| Intuitive Surgical | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JELMYTO$375,543
- ADSTILADRIN$76,179
- ZUSDURI$68,047
- Erleada$2,540
- OPDIVO$2,300
- IMFINZI$2,148
- ANKTIVA$1,512
- Kerecis Omega3 SurgiClose$452
- Balversa$247
- LithoVue$207
- Kerecis Omega3 GraftGuide$151
- Kerecis Omega3 Marigen$151
- AQUABEAM SYSTEM$146
- Nubeqa$143
- Xofigo$143
- GENERAL ERECTILE DYSFUNCTION$134
- PADCEV$129
- AMS$123
How this compares
$574,807 in reported general payments places this provider in the 95th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 38 | $722 |
| Ciprofloxacin Hcl | 13 | $104 |
Paid to pharmacies, not to this prescriber.
Other urology in New York
- Bilal ChughtaiNew York$658K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Ketan BadaniNew York$285K
- Michael GrassoNew York$284K
- Mantu GuptaNew York$229K
- Robin SmithNew York$215K
- Jean-Francois EidNew York$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.